Paper - WANFANG MED ONLINE

You Position: Home > Paper

辅助生殖技术与卵巢交界性肿瘤关系的研究进展

( views:259, downloads:398 )

Author:: No author available

Journal Title:: Chinese Journal of Obstetrics and Gynecology

Issue:: 9

DOI:: 10.3760/cma.j.issn.0529-567x.2017.09.016

Key Word:: No keyword available

Abstract：辅助生殖技术(ART)作为治疗不孕症的主要手段,常常使用促排卵药物来刺激卵巢以获取更多的卵母细胞,因此,ART在受益于无数家庭的同时,是否会增加卵巢上皮性肿瘤尤其是卵巢交界性上皮性肿瘤(BOT)的发生风险,这是生殖科医师和妇瘤科医师备受关注的问题.BOT约占卵巢上皮性肿瘤的10%~15%[1],好发于生育年龄妇女,约30%的患者<40岁.尚未生育的BOT患者常常采取保留生育功能的手术治疗.对术后有生育要求而不能自然妊娠的BOT患者是否可以选择ART助孕治疗,以及ART是否会增加BOT术后复发的风险,这使得ART与BOT之间的关系受到高度关注.

Reference

[1]温灏,吴小华.卵巢交界性肿瘤的治疗进展[J].2010,(12).
[2]中华医学会妇科肿瘤学分会.妇科恶性肿瘤保留生育功能临床诊治指南[J].2014,(4).
[3]陶陶,曹冬焱,杨佳欣,等.卵巢交界性上皮性肿瘤复发相关因素及术后生育状况的分析[J].2010,(19).
[4]Larsen, I. K.,Storeng, R.,Myklebust, T. A.,etc.Cancer risk among parous women following assisted reproductive technology[J].2015,30(8).
[5]David E Tourgeman,Jean J Lu,Robert Boostanfar,etc.Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro[J].2002,78(5).
[6]Zikan,M.,Fischerova,D.,Dundr,P.,etc.Diagnosis, treatment, and follow-up of borderline ovarian tumors[J].2012,17(12).
[7]Finn,J.C.,Preen,D.B.,Hart,R.,etc.In vitro fertilization is associated with an increased risk of borderline ovarian tumours[J].2013,129(2).
[8]Trillsch,F.,Mahner,S.,Woelber,L.,etc.Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: Results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study[J].2014,25(7).
[9]Chan Woo, Park,Kwang Moon, Yang,Hye Ok, Kim,etc.Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment.[J].2007,22 Suppl.
[10]Le Bouedec G,Chene G,Penault Llorca F.Ovarian epithelial dysplasia after ovulation induction: time and dose effects.[J].2009,24(1).
[11]W J, Murdoch,R S, Townsend,A C, McDonnel.Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis.[J].2001,65(5).
[12]蒋芳,向阳.晚期卵巢交界性肿瘤综合治疗与预后[J].2015,(11).
[13]Aktan M,Acar A,Akyurek C,etc.Effects of ovulation induction on ovarian morphology: an animal study.[J].2004,14(4).
[14]Asher Shushan,Ora Paltiel,Jose Iscovich,etc.Human menopausal gonadotropin and the risk of epithelial ovarian cancer[J].1996,65(1).
[15]van Leeuwen FE,Klip H,Mooij TM,etc.Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.[J].2011,26(12).
[16]Morice,P.,Dara?,E.,Fauvet,R.L.,etc.Fertility and borderline ovarian tumor: A systematic review of conservative management, risk of recurrence and alternative options[J].2013,19(2).
[17]Stickeler E,Runnebaum IB.Epidemiological and molecular aspects of ovarian cancer risk.[J].2001,127(2).
[18]Bjornholt, Sarah Marie,Kjaer, Susanne Kruger,Nielsen, Thor Schutt Svane,etc.Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study[J].2015,30(1).
[19]Vasconcelos, Ines,Mendes, Miguel de Sousa.Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence risk[J].2015,51(5).
[20]Attar, E.,Berkman, S.,Topuz, S.,etc.Evolutive peritoneal disease after conservative management and the use of infertility drugs in a patient with stage IIIC borderline micro-papillary serous carcinoma (MPSC) of the ovary: Case report[J].2004,19(6).
[21]Philipp, Harter,David, Gershenson,Catherine, Lhomme,etc.Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).[J].2014,24.
[22]Hagenfeldt K,Nilsson S,Conner P,etc.Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.[J].2009,91(4).
[23]H W, Nijman,C W, Burger,J P, Baak,etc.Borderline malignancy of the ovary and controlled hyperstimulation, a report of 2 cases.[J].1992,28A(12).
[24]Robert J, Morgan,Deborah K, Armstrong,Ronald D, Alvarez,etc.Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.[J].2016.
[25]A K, Godwin,J R, Testa,L M, Handel,etc.Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer.[J].1992,84(8).
[26]William J, Murdoch.Carcinogenic potential of ovulatory genotoxicity.[J].2005,73(4).
[27]李艺,崔恒.卵巢交界性肿瘤术后生育时机妊娠率及分娩后处理[J].2015,(11).
[28]Sozos J. Fasouliotis,Owen Davis,Glenn Schattman,etc.Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors: A preliminary report[J].2004,82(3).
[29]Anne Fortin,Philippe Morice,Anne Thoury,etc.Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study[J].2007,87(3).
[30]J A M, Kremer,R S G M, Bots,B, Cohlen,etc.[Ten years of results of in-vitro fertilisation in the Netherlands 1996-2005].[J].2008,152(3).
[31]M, Atlas,J, Menczer.Massive hyperstimulation and borderline carcinoma of the ovary. A possible association.[J].1982,61(3).
[32]Rey A,Uzan C,Kane A.Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.[J].2009,14(6).
[33]Trivella,M.,Mavromatis,I.,Sotiraki,M.,etc.Controlled ovarian hyperstimulation for IVF: Impact on ovarian, endometrial and cervical cancer-A systematic review and meta-analysis[J].2013,19(2).
[34]Davidson,B.,Kaern,J.,Tropé,C.G..Borderline ovarian tumours[J].2012,26(3).
[35]Raffaèle Fauvet,Christophe Poncelet,Joëlle Boccara,etc.Fertility after conservative treatment for borderline ovarian tumors: A French multicenter study[J].2005,83(2).
[36]M A, Rossing,J R, Daling,N S, Weiss,etc.Ovarian tumors in a cohort of infertile women.[J].1994,331(12).